Cargando…

Transgelin in bladder cancer: A potential biomarker and therapeutic target

Detalles Bibliográficos
Autores principales:	Li, Wei-Ming, Wu, Wen-Jeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838370/ https://www.ncbi.nlm.nih.gov/pubmed/31631042 http://dx.doi.org/10.1016/j.ebiom.2019.09.011

Ejemplares similares

Elevated transgelin/TNS1 expression is a potential biomarker in human colorectal cancer
por: Zhou, Huimin, et al.
Publicado: (2017)

Transgelin as a potential target in the reversibility of pulmonary arterial hypertension secondary to congenital heart disease
por: Huang, Li, et al.
Publicado: (2018)

Evolution and function of calponin and transgelin
por: Hsieh, Tzu-Bou, et al.
Publicado: (2023)

Salvianolic acid A targeting the transgelin-actin complex to enhance vasoconstriction
por: Zhong, Weilong, et al.
Publicado: (2018)

Transgelin Up-Regulation in Obstructive Nephropathy
por: Karagianni, Fani, et al.
Publicado: (2013)

Bilirubin: A Potential Biomarker and Therapeutic Target for Diabetic Nephropathy
por: Hull, Travis D., et al.
Publicado: (2014)

TGF-β-induced transgelin promotes bladder cancer metastasis by regulating epithelial-mesenchymal transition and invadopodia formation
por: Chen, Zhicong, et al.
Publicado: (2019)

Cell-permeable transgelin-2 as a potent therapeutic for dendritic cell-based cancer immunotherapy
por: Kim, Hye-Ran, et al.
Publicado: (2021)

Transgelins: Cytoskeletal Associated Proteins Implicated in the Metastasis of Colorectal Cancer
por: Liu, Jingwen, et al.
Publicado: (2020)

Deglycosylated Azithromycin Targets Transgelin to Enhance Intestinal Smooth Muscle Function
por: Zhong, Weilong, et al.
Publicado: (2020)

Transgelin interacts with PARP1 in human colon cancer cells
por: Lew, Zhen-xian, et al.
Publicado: (2020)

Differential Expression of Drosophila Transgelins Throughout Development
por: Vakaloglou, Katerina M., et al.
Publicado: (2021)

Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer
por: Sun, Yan, et al.
Publicado: (2018)

Role of transgelin-2 in diabetes-associated pancreatic ductal adenocarcinoma
por: Sun, Yan, et al.
Publicado: (2017)

Transgelin-2: A Double-Edged Sword in Immunity and Cancer Metastasis
por: Kim, Hye-Ran, et al.
Publicado: (2021)

Natural bioactive compounds: a potential therapeutic strategy to sensitize bladder cancer to cisplatin treatment?
por: Ruiz de Porras, Vicenç
Publicado: (2022)

Transgelin gene is frequently downregulated by promoter DNA hypermethylation in breast cancer
por: Sayar, Nilufer, et al.
Publicado: (2015)

Expression of Cofilin-1 and Transgelin in Esophageal Squamous Cell Carcinoma
por: Zhang, Yan, et al.
Publicado: (2015)

Transgelin-2 Involves in the Apoptosis of Colorectal Cancer Cells Induced by Tanshinone-IIA
por: Zhang, Yingru, et al.
Publicado: (2022)

Plasma-type gelsolin in subarachnoid hemorrhage: novel biomarker today, therapeutic target tomorrow?
por: Chou, Sherry Hsiang-Yi, et al.
Publicado: (2014)

Cellular and Molecular Signaling as Targets for Cancer Vaccine Therapeutics
por: Wei, Wen-Chi, et al.
Publicado: (2022)

Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets
por: Morera, Daley S, et al.
Publicado: (2017)

Transgelin increases metastatic potential of colorectal cancer cells in vivo and alters expression of genes involved in cell motility
por: Zhou, Hui-min, et al.
Publicado: (2016)

Transgelin-2 in Multiple Myeloma: A New Marker of Renal Impairment?
por: Woziwodzka, Karolina, et al.
Publicado: (2021)

Transgelin promotes lung cancer progression via activation of cancer-associated fibroblasts with enhanced IL-6 release
por: Sun, Chanjun, et al.
Publicado: (2023)

Vitamin D as a Potential Therapeutic Target and Prognostic Marker for Colorectal Cancer
por: Bintintan, Vasile V.
Publicado: (2018)

Complement in Lupus: Biomarker, Therapeutic Target, or a Little Bit of Both?
por: Cantarelli, Chiara, et al.
Publicado: (2021)

Transgelin, a p53 and PTEN-Upregulated Gene, Inhibits the Cell Proliferation and Invasion of Human Bladder Carcinoma Cells In Vitro and In Vivo
por: Tsui, Ke-Hung, et al.
Publicado: (2019)

Transgelin promotes ferroptosis to inhibit the malignant progression of esophageal squamous cell carcinoma
por: Chen, Qiuyu, et al.
Publicado: (2023)

Cancer biomarkers and targeted therapies
por: Shen, Zhiyuan
Publicado: (2013)

Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia
por: Davidson, Michael H.
Publicado: (2015)

Energy metabolism pathways in breast cancer progression: The reprogramming, crosstalk, and potential therapeutic targets
por: Zheng, Xuewei, et al.
Publicado: (2022)

Cartilage Oligomeric Matrix Protein promotes epithelial-mesenchymal transition by interacting with Transgelin in Colorectal Cancer
por: Zhong, Weilong, et al.
Publicado: (2020)

αTAT1: a potential therapeutic target in cancer?
por: Chien, J-Y, et al.
Publicado: (2016)

Bioinformatics analysis reveals the roles of cytoskeleton protein transgelin in occurrence and development of proteinuria
por: Ding, Yingxue, et al.
Publicado: (2021)

Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet
por: Martinez, Victor G., et al.
Publicado: (2019)

Identifying genes that regulate bone remodeling as potential therapeutic targets
por: Krane, Stephen M.
Publicado: (2005)

Developments in the Role of Endothelin-1 in Atherosclerosis: A Potential Therapeutic Target?
por: Sutton, Greg, et al.
Publicado: (2019)

The missing middle of sickle therapeutics: Multi‐agent therapy, targeting risk, using biomarkers
por: Hebbel, Robert P., et al.
Publicado: (2018)

Purification and properties of transgelin: a transformation and shape change sensitive actin-gelling protein
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_o1qv517d8bt1v2e5h7omvs4cb9